Pharyngeal Carcinoma — Trials

Pharyngeal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

994 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 357
Recruiting: 191
Ph III recruiting: 58
Growth YoY: +6.7%
Industry share: 8%
Top sponsor: Sun Yat-sen University
Termination share: 31.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (85)

clinicaltrialsPublishedShowing 101–109 of 109 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01271439	Study of Chemoradiotherapy Combined With Cetuximab in Nasopharyngeal Carcinoma(REPLACE)	completed	Phase 2	60	Sun Yat-sen UniversityOTHER	1	Aug 13, 2013	clinicaltrials
NCT00410826	Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer	completed	Phase 2	204	University of WashingtonOTHER	1	May 10, 2013